L26/P-457 Recipient and partner predictors of live birth in donor oocyte cycles: a UK retrospective analysis
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S.H.Y. Wan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Study question What recipient and partner characteristics are predictive of live birth following donor oocyte treatment in the United Kingdom? Summary answer Advancing recipient age and black ethnicity independently predict reduced live birth rates in donor egg IVF, with black recipients facing a 50% reduction in odds. What is known already Donor-oocyte IVF is used for multiple indications, with age-related fertility decline a major driver of demand according to Human Fertilisation and Embryology Authority (HFEA) data. While donor oocytes mitigate some age-related effects, they do not fully overcome them, and recipients lack validated prognostic models used in autologous treatment. Success depends on factors such as oocyte cohort size and surplus embryos creation, yet no UK population-level analyses quantify recipient-specific independent predictors. This evidence gap is significant, as most donor cycles are self-funded, underscoring the need to support informed decision-making, manage cumulative success expectations, and guide development of a donor-egg prediction model. Study design, size, duration A preliminary retrospective analysis was conducted on anonymised data from the Human Fertilisation and Embryology Authority (HFEA) register from 2017-2018. A total of 8,677 donor egg cycles were included in the multivariate analysis. Participants/materials, setting, methods Multivariate logistic regression models were utilised to identify independent predictors of Live Birth Rate (LBR) across 8,677 cycles. Adjusted Odds Ratios (aOR) and 95% confidence intervals were calculated, controlling for confounders including recipient age (continuous), ethnicity (reference: White), sperm source, and number of embryos transferred. Statistical significance was defined as p < 0.05. This approach isolated recipient-specific prognostic factors. Main results and the role of chance Multivariate logistic regression analysis of 8,677 donor cycles identified the number of embryos transferred as the strongest modifiable predictor of live birth (aOR 2.49, 95% CI 2.28–2.71; p < 0.001). Significant racial disparities were observed, with Black recipients demonstrating a 50% reduction in odds compared to White recipients (aOR 0.50, 95% CI 0.37–0.67; p < 0.001). Recipient age was a statistically significant predictor, with a 1% decline in odds per year (aOR 0.99, 95% CI 0.98–0.997; p = 0.004). Patients with ovulatory disorders had significantly higher odds of success (aOR 1.41, 95% CI 1.15–1.74; p = 0.001). No statistically significant associations were found for tubal disease (aOR 1.04, 95% CI 0.83–1.32; p = 0.715), male factor infertility (aOR 0.97, 95% CI 0.86–1.09; p = 0.587), endometriosis (aOR 0.95, 95% CI 0.74–1.23; p = 0.710), or unexplained infertility (aOR 1.08, 95% CI 0.95–1.24; p = 0.243). Similarly, neither sperm source (Partner vs. Donor: aOR 0.94, 95% CI 0.85–1.05; p = 0.290) nor the number of previous failed IVF cycles (aOR 0.99, 95% CI 0.96–1.02; p = 0.417) were significant predictors. In cycles using partner sperm (n = 6,242), paternal age was not associated with live birth (aOR 0.997, 95% CI 0.99–1.01; p = 0.411). Limitations, reasons for caution The analysis is limited by unmeasured confounders (e.g. BMI, smoking and socioeconomic status), unlinked treatment cycles, and potential inconsistencies arising from recent HFEA data migration. As advised by the HFEA, findings should be interpreted cautiously and require validation against updated datasets and the comprehensive Research Register to ensure accuracy. Wider implications of the findings The observed 50% reduction in live birth odds for Black recipients parallels severe maternal inequalities highlighted by MBRRACE-UK. Future results validation using individual cycle personalised data from the comprehensive HFEA Research Register is planned. If confirmed, systemic and healthcare-mediated drivers must be investigated to develop targeted interventions addressing these inequalities. Trial registration number No
Zitieren
APA
Wan, S., Bakhbakhi, D., Lenguerrand, E., & Morris, G. (2026). L26/P-457 Recipient and partner predictors of live birth in donor oocyte cycles: a UK retrospective analysis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.791
Vancouver
Wan S, Bakhbakhi D, Lenguerrand E, Morris G. L26/P-457 Recipient and partner predictors of live birth in donor oocyte cycles: a UK retrospective analysis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.791
BibTeX
@article{Wan2026,
author = {Wan, S.H.Y. and Bakhbakhi, D. and Lenguerrand, E. and Morris, G.},
title = {L26/P-457 Recipient and partner predictors of live birth in donor oocyte cycles: a UK retrospective analysis},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.791}
}
EUVIMED